Pfizer recalls dopamine injection lot; two Phase 3 trials remain not yet recruitingSep 24Weekly roundup, 4 itemsdopaminePfizer
Pfizer wins Xeljanz label update; registers four new trials across RSV, eczema, sleep apneaSep 16Weekly roundup, 7 itemsabrocitinibberobenatide
FDA approves ZAVZPRET label update; Pfizer registers RSVpreF and prostate cancer studiesAug 21Weekly roundup, 7 itemsBioNTech SEPenbraya
Pfizer wins five FDA label updates for tofacitinib, ritlecitinib, abrocitinib; Crohn's trial haltedJul 2Weekly roundup, 12 itemsabrocitinibatirmociclib
Sign inSign in